| Name | Title | Contact Details |
|---|
NYU Langone Medical Center is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in New York, NY. To find more information about NYU Langone Medical Center, please visit www.nyumc.org
Sidney Regional Medical Center (SRMC) is a 25-bed, non-profit CAH designated healthcare facility. SRMC is committed to providing high-quality compassionate care by offering a wide array of services and surgeries. SRMC has been a part of the community since 1955.
Zotos International, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Darien, CT. To find more information about Zotos International, Inc., please visit www.zotos.com
Tock is a comprehensive platform built to fundamentally change the way restaurants think about and run their business. This includes a robust reservation, guest, and table management system for restaurants of all sizes across the globe.
ContraVir is a biopharmaceutical company focused primarily on the development of drugs to treat herpes zoster, or shingles, which is an infection caused by the reactivation of varicella zoster virus or VZV. Our lead candidate, FV-100, is an orally available nucleoside analogue prodrug of CF-1743 that we are developing for the treatment of shingles. Published preclinical studies demonstrate that FV-100 is significantly more potent against VZV than acyclovir, valacyclovir, and famciclovir, the FDA-approved drugs used for the treatment of shingles. Preclinical studies further demonstrate that FV-100 has a more rapid onset of antiviral activity, and may fully inhibit the replication of VZV more rapidly than these drugs at significantly lower concentration levels. In addition, pharmacokinetic data from completed phase 1 and 2 clinical trials suggest that FV-100 has the potential to demonstrate antiviral activity when dosed orally once-a-day at significantly lower levels than valacyclovir, acyclovir, and famciclovir.